Publicité
La bourse ferme dans 3 h 7 min
  • CAC 40

    8 224,07
    +19,26 (+0,23 %)
     
  • Euro Stoxx 50

    5 091,09
    +9,35 (+0,18 %)
     
  • Dow Jones

    39 760,08
    +477,75 (+1,22 %)
     
  • EUR/USD

    1,0810
    -0,0020 (-0,18 %)
     
  • Gold future

    2 232,60
    +19,90 (+0,90 %)
     
  • Bitcoin EUR

    65 388,87
    -540,70 (-0,82 %)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00 %)
     
  • Pétrole WTI

    82,48
    +1,13 (+1,39 %)
     
  • DAX

    18 487,87
    +10,78 (+0,06 %)
     
  • FTSE 100

    7 953,05
    +21,07 (+0,27 %)
     
  • Nasdaq

    16 399,52
    +83,82 (+0,51 %)
     
  • S&P 500

    5 248,49
    +44,91 (+0,86 %)
     
  • Nikkei 225

    40 168,07
    -594,66 (-1,46 %)
     
  • HANG SENG

    16 541,42
    +148,58 (+0,91 %)
     
  • GBP/USD

    1,2637
    -0,0001 (-0,01 %)
     

Microcarrier Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.

New York, March 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Microcarrier Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" - https://www.reportlinker.com/p06036756/?utm_source=GNW


Many of the current biologics in the pipeline are targeting the indications, which are small-molecule dominated and have a large patient pool. This represents that in the forecast period the trend of biologics could enter several of the non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.

In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.

Key Market Trends
Cell Therapy is Expected to Show Fastest Growth by Application, Over the Forecast Period

Microcarriers help in cost-effective cell production i.e they contribute to reducing fixed as well as variable costs during the large scale manufacturing. With technological advancements, the current scenario has changed and the significance of microcarriers in cell therapy has increased. For instance, dissolvable microcarriers are currently there in the market that is composed of cross-linked polysaccharide polymers that can be efficiently dissolved during the cell harvest step. As the microcarriers get completely dissolved, there is no need for the separation and simply, the downstream process goes well. Therefore, these microcarriers are considered as beneficial beads for large scale cell production or cell therapy application.

Along with the above-mentioned statements, another factor that is responsible for the growth of cell therapy applications of microcarriers is that companies are currently focusing on the provision of microcarriers that contribute to the large scale and cost-effective production. For example Corning Incorporated provides dissolvable microcarriers. These factors boost the growth in cell therapy applications.

North America is Expected to Dominate the Market Over the Forecast Period

North America region is believed to have the largest share in the microcarrier market. This is majorly due to the rising gene and cell therapy research in the region along with the associations that are supporting this research. For instance, the American Society of Gene and Cell Therapy is responsible for the funding of the research and also, this society is forcing the biopharmaceutical and biotech companies to improve their R&D.

Along with that, the United States is witnessing high and rapid growth in the biologics and biosimilar Industry which is one of the major factors driving the microcarrier market in this region.

Competitive Landscape
The Microcarrier market is mostly inclusive of the global players and few companies that are currently dominating the market include Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Danaher Corporation (Pall Corporation), and GE Healthcare. The competition in the market is expected to increase as new companies are also coming up in the market.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Read the full report: https://www.reportlinker.com/p06036756/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001